share_log

BMO Capital Initiates Coverage On Jasper Therapeutics With Outperform Rating, Announces Price Target of $63

BMO Capital Initiates Coverage On Jasper Therapeutics With Outperform Rating, Announces Price Target of $63

BMO资本对Jasper Therapeutics启动覆盖,给予优于大盘评级,宣布目标价为63美元。
Benzinga ·  12/06 05:50  · 评级/大行评级

BMO Capital analyst Etzer Darout initiates coverage on Jasper Therapeutics (NASDAQ:JSPR) with a Outperform rating and announces Price Target of $63.

BMO Capital分析师埃策·达鲁特以跑赢大盘的评级启动了对Jasper Therapeutics(纳斯达克股票代码:JSPR)的报道,并宣布目标股价为63美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发